Evidence map›Paper›PMID 34189857›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

Influenza Virus Infects and Depletes Activated Adaptive Immune Responders.

Caitlin D Bohannon, Zachary Ende, Weiping Cao, Wadzanai P Mboko, Priya Ranjan, Amrita Kumar, Margarita Mishina, Samuel Amoah, Shivaprakash Gangappa, Suresh K Mittal and 6 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cycling and activated CD8BMC immunology · 2022
    Article
  8. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Caitlin D BohannonInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.
Zachary EndeInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.
Weiping CaoInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.
Wadzanai P MbokoInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.
Priya RanjanInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.
Amrita KumarInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.
Margarita MishinaInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.
Samuel AmoahInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.
Shivaprakash GangappaInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.
Suresh K MittalDepartment of Comparative Pathobiology and Purdue Institute for Inflammation, Immunology, and Infectious Disease, Purdue University, West Lafayette, IN, 47907, USA.
Jonathan F LovellDepartment of Biomedical Engineering, State University of New York at Buffalo, Buffalo, NY, 14260, USA.
Adolfo García-SastreGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Blaine A PfeiferDepartment of Chemical and Biological Engineering, School of Engineering and Applied Sciences, State University of New York at Buffalo, Buffalo, NY, 14260, USA.
Bruce A DavidsonDepartment of Anesthesiology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, 14260, USA.
Paul KnightDepartment of Anesthesiology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, 14260, USA.
Suryaprakash SambharaInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.ORCID 0000-0002-4715-5793
Centers for Disease Control and Prevention · USBuffalo State University · USOak Ridge Associated Universities · USPurdue University West Lafayette · USTisch Hospital · USUniversity at Buffalo, State University of New York · USVA Western New York Healthcare System · US

Funding

Adenoviral Vector-based Pandemic Influenza VaccineR01AI059374 · NIAID · PURDUE UNIVERSITY WEST LAFAYETTE · PI SURESH K MITTAL · 2005 to 2026
$5.0M
Immunotherapy for acute lung injury secondary to influenzaR01HL151498 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI KNIGHT III, PAUL R · 2020 to 2023
$1.7M
The efficacy of Liposomal Encapsulation of Polysaccharides pneumococcal vaccine in protecting aged hosts against invasive Streptococcus pneumoniae infections in murine modelsR21AG064215 · NIA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BOU GHANEM, ELSA, PFEIFER, BLAINE A. · 2019 to 2020
$436k
CDC HHSCenter for Research on Influenza Pathogenesis and Transmission 75N93019R00028Centers of Excellence for Influenza Research and ResponseNational Institute of Allergy and Infectious Diseases AG064215NHLBI NIH HHS HL151498NHLBI NIH HHS R01 HL151498NIAID NIH HHS HHSN272201400008CNIAID NIH HHS R01 AI059374NIA NIH HHS R21 AG064215
6 · The paper itself

Abstract

Influenza infections cause several million cases of severe respiratory illness, hospitalizations, and hundreds of thousands of deaths globally. Secondary infections are a leading cause of influenza's high morbidity and mortality, and significantly factored into the severity of the 1918, 1968, and 2009 pandemics. Furthermore, there is an increased incidence of other respiratory infections even in vaccinated individuals during influenza season. Putative mechanisms responsible for vaccine failures against influenza as well as other respiratory infections during influenza season are investigated. Peripheral blood mononuclear cells (PBMCs) are used from influenza vaccinated individuals to assess antigen-specific responses to influenza, measles, and varicella. The observations made in humans to a mouse model to unravel the mechanism is confirmed and extended. Infection with influenza virus suppresses an ongoing adaptive response to vaccination against influenza as well as other respiratory pathogens, i.e., Adenovirus and Streptococcus pneumoniae by preferentially infecting and killing activated lymphocytes which express elevated levels of sialic acid receptors. These findings propose a new mechanism for the high incidence of secondary respiratory infections due to bacteria and other viruses as well as vaccine failures to influenza and other respiratory pathogens even in immune individuals due to influenza viral infections.

Indexed as

Adaptive ImmunityAnimalsDisease Models, AnimalFemaleHumansInfluenza, HumanMiceMice, Inbred BALB Cadenovirusflowcytometryimmunosuppressioninfluenzapneumococcus

Identifiers

PMID34189857
PMCPMC8373117
OpenAlexW3175809946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.